Skip to content

Clinical trials

Phase 4 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 4 Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20038
20045
20057
200610
20079
200811
20094
20105
20115
20128
20134
20146
20154
20164
20173
20183
20193
20202
20212
20225
20232
20244
20251
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Unknown status17
Recruiting10
Terminated8
Withdrawn5
Not yet recruiting4
Active, not recruiting4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis7
Novartis Pharmaceuticals7
Avid Radiopharmaceuticals4
Eisai Inc.4
Eisai Korea Inc.4
NYU Langone Health4
New York State Psychiatric Institute4
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.3
VA Office of Research and Development3
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease136
Dementia31
Cognitive Dysfunction13
Psychomotor Agitation7
Lethargy5
Plaque, Amyloid4
Psychotic Disorders4
Cognition Disorders3
Dementia, Vascular3
Lewy Body Disease3

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.